Letters Antihistamines for anaphylaxis?

Primary outcome measures

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b3368 (Published 18 August 2009) Cite this as: BMJ 2009;339:b3368
  1. Simon G A Brown, professor, emergency medicine1
  1. 1Royal Perth Hospital, University of Western Australia, Perth, WA 6000, Australia
  1. simon.brown{at}uwa.edu.au

    Andreae and Andreae recommend that future trials of antihistamines in anaphylaxis should use a primary outcome of “whether antihistamines result in reduced mortality.”1

    Given that death …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe